Literature DB >> 22865875

Alzheimer's disease in a dish: promises and challenges of human stem cell models.

Jessica E Young1, Lawrence S B Goldstein.   

Abstract

Human pluripotent stem cells can differentiate into disease-relevant cell types, which capture the unique genome of an individual patient and provide insight into pathological mechanisms of human disease. Recently, human stem cell models for Alzheimer's disease (AD), the most common neurodegenerative dementia, have been described. Stem cell-derived neurons from patients with familial and sporadic AD and Down's syndrome recapitulate human disease phenotypes such as amyloid β peptide production, hyperphosphorylation of tau protein and endosomal abnormalities. Treatment of human neurons with small molecules can modulate these phenotypes, demonstrating the utility of this system for drug development and screening. This review will highlight the current AD stem cell models and discuss the remaining challenges and potential future directions of this field.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22865875      PMCID: PMC3459645          DOI: 10.1093/hmg/dds319

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  75 in total

1.  CSF biomarkers for Alzheimer's disease: current utility and potential future use.

Authors:  David M Holtzman
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

2.  Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations.

Authors:  Frank Soldner; Josée Laganière; Albert W Cheng; Dirk Hockemeyer; Qing Gao; Raaji Alagappan; Vikram Khurana; Lawrence I Golbe; Richard H Myers; Susan Lindquist; Lei Zhang; Dmitry Guschin; Lauren K Fong; B Joseph Vu; Xiangdong Meng; Fyodor D Urnov; Edward J Rebar; Philip D Gregory; H Steve Zhang; Rudolf Jaenisch
Journal:  Cell       Date:  2011-07-14       Impact factor: 41.582

Review 3.  Induced pluripotent stem cells (iPSCs) and neurological disease modeling: progress and promises.

Authors:  Maria C Marchetto; Kristen J Brennand; Leah F Boyer; Fred H Gage
Journal:  Hum Mol Genet       Date:  2011-08-09       Impact factor: 6.150

Review 4.  Stem cell technology for neurodegenerative diseases.

Authors:  J Simon Lunn; Stacey A Sakowski; Junguk Hur; Eva L Feldman
Journal:  Ann Neurol       Date:  2011-09       Impact factor: 10.422

5.  Modeling familial Alzheimer's disease with induced pluripotent stem cells.

Authors:  Takuya Yagi; Daisuke Ito; Yohei Okada; Wado Akamatsu; Yoshihiro Nihei; Takahito Yoshizaki; Shinya Yamanaka; Hideyuki Okano; Norihiro Suzuki
Journal:  Hum Mol Genet       Date:  2011-09-07       Impact factor: 6.150

6.  Insensitivity to Abeta42-lowering nonsteroidal anti-inflammatory drugs and gamma-secretase inhibitors is common among aggressive presenilin-1 mutations.

Authors:  Eva Czirr; Stefanie Leuchtenberger; Cornelia Dorner-Ciossek; Anna Schneider; Mathias Jucker; Edward H Koo; Claus U Pietrzik; Karlheinz Baumann; Sascha Weggen
Journal:  J Biol Chem       Date:  2007-06-15       Impact factor: 5.157

Review 7.  Autophagy, amyloidogenesis and Alzheimer disease.

Authors:  Ralph A Nixon
Journal:  J Cell Sci       Date:  2007-12-01       Impact factor: 5.285

8.  CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects.

Authors:  K Buerger; S J Teipel; R Zinkowski; K Blennow; H Arai; R Engel; K Hofmann-Kiefer; C McCulloch; U Ptok; R Heun; N Andreasen; J DeBernardis; D Kerkman; H- J Moeller; P Davies; H Hampel
Journal:  Neurology       Date:  2002-08-27       Impact factor: 9.910

9.  Somatic coding mutations in human induced pluripotent stem cells.

Authors:  Athurva Gore; Zhe Li; Ho-Lim Fung; Jessica E Young; Suneet Agarwal; Jessica Antosiewicz-Bourget; Isabel Canto; Alessandra Giorgetti; Mason A Israel; Evangelos Kiskinis; Je-Hyuk Lee; Yuin-Han Loh; Philip D Manos; Nuria Montserrat; Athanasia D Panopoulos; Sergio Ruiz; Melissa L Wilbert; Junying Yu; Ewen F Kirkness; Juan Carlos Izpisua Belmonte; Derrick J Rossi; James A Thomson; Kevin Eggan; George Q Daley; Lawrence S B Goldstein; Kun Zhang
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

10.  Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.

Authors:  Gabsang Lee; Eirini P Papapetrou; Hyesoo Kim; Stuart M Chambers; Mark J Tomishima; Christopher A Fasano; Yosif M Ganat; Jayanthi Menon; Fumiko Shimizu; Agnes Viale; Viviane Tabar; Michel Sadelain; Lorenz Studer
Journal:  Nature       Date:  2009-08-19       Impact factor: 49.962

View more
  25 in total

Review 1.  Alzheimer's in 3D culture: challenges and perspectives.

Authors:  Carla D'Avanzo; Jenna Aronson; Young Hye Kim; Se Hoon Choi; Rudolph E Tanzi; Doo Yeon Kim
Journal:  Bioessays       Date:  2015-08-07       Impact factor: 4.345

Review 2.  Progress and prospects for genetic modification of nonhuman primate models in biomedical research.

Authors:  Anthony W S Chan
Journal:  ILAR J       Date:  2013

Review 3.  Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy.

Authors:  Subrata Pramanik; Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2016-11-05       Impact factor: 5.590

4.  Inducible CRISPR genome editing platform in naive human embryonic stem cells reveals JARID2 function in self-renewal.

Authors:  Amy Ferreccio; Julie Mathieu; Damien Detraux; Logeshwaran Somasundaram; Christopher Cavanaugh; Bryce Sopher; Karin Fischer; Thomas Bello; Abdiasis M Hussein; Shiri Levy; Savannah Cook; Sonia B Sidhu; Filippo Artoni; Nathan J Palpant; Hans Reinecke; Yuliang Wang; Patrick Paddison; Charles Murry; Suman Jayadev; Carol Ware; Hannele Ruohola-Baker
Journal:  Cell Cycle       Date:  2018-04-05       Impact factor: 4.534

5.  A 3D human neural cell culture system for modeling Alzheimer's disease.

Authors:  Young Hye Kim; Se Hoon Choi; Carla D'Avanzo; Matthias Hebisch; Christopher Sliwinski; Enjana Bylykbashi; Kevin J Washicosky; Justin B Klee; Oliver Brüstle; Rudolph E Tanzi; Doo Yeon Kim
Journal:  Nat Protoc       Date:  2015-06-11       Impact factor: 13.491

Review 6.  Drug repositioning approaches for the discovery of new therapeutics for Alzheimer's disease.

Authors:  Tae-Wan Kim
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

Review 7.  Human-induced pluripotent stem cells: potential for neurodegenerative diseases.

Authors:  Christopher A Ross; Sergey S Akimov
Journal:  Hum Mol Genet       Date:  2014-05-13       Impact factor: 6.150

Review 8.  Genomic editing tools to model human diseases with isogenic pluripotent stem cells.

Authors:  Huen Suk Kim; Jeffrey M Bernitz; Dung-Fang Lee; Ihor R Lemischka
Journal:  Stem Cells Dev       Date:  2014-10-07       Impact factor: 3.272

Review 9.  "Seq-ing" insights into the epigenetics of neuronal gene regulation.

Authors:  Francesca Telese; Amir Gamliel; Dorota Skowronska-Krawczyk; Ivan Garcia-Bassets; Michael G Rosenfeld
Journal:  Neuron       Date:  2013-02-20       Impact factor: 17.173

10.  Alzheimer's disease-related amyloid-β induces synaptotoxicity in human iPS cell-derived neurons.

Authors:  K Nieweg; A Andreyeva; B van Stegen; G Tanriöver; K Gottmann
Journal:  Cell Death Dis       Date:  2015-04-02       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.